The Federal Trade Commission argued against the proposed merger between two Chicago-area health systems in a federal appeals court Friday, defending its market definitions that were rejected by a lower court in June.
The CMS is asking the public for information about providers and organizations that may be steering Medicare- or Medicaid-eligible patients toward the Affordable Care Act's insurance exchanges in order to receive higher reimbursement rates.
This week, Pennsylvania's Department of Human Services expects to award contracts worth more than $7 billion annually that cover almost 421,000 low-income, disabled adults. But the contracts were scheduled to be awarded in June.
A majority of people would participate in President Barack Obama's Precision Medicine Initiative, a volunteer federal program that collects patient data to advance research, according to a new survey.
Wanted: Volunteers willing to be infected with the Zika virus for science. It may sound bizarre, but researchers are planning just such a study—this winter, when mosquitoes aren't biting—to help speed development of much-needed Zika vaccines.
The drug with by far the highest cost, despite the lowest claim count of the 10 most expensive, was Gilead's hepatitis C treatment Sovaldi at more than $3.1 billion. Next were Nexium, which treats gastroesophageal reflux disease, and the cholesterol drug Crestor.
Illinois Gov. Bruce Rauner has signed legislation named for a 5-year-old Illinois girl that will require hospitals to be better prepared to treat patients with sepsis or septic shock.
Billionaire philanthropist and former New York mayor Michael Bloomberg has a new job—as global ambassador for the U.N. health agency with a mandate to help reduce deaths from prevalent diseases, traffic accidents, tobacco, alcohol and obesity.
Officials say they've found another instance of a potentially deadly bacterium inside a Maryland hospital that was shut down earlier this month.
A San Diego woman's harrowing account of her aunt's death last month under California's new physician aid-in-dying law suggests that healthcare providers still have a long way to go to make the process work well for terminally ill patients.
Kaiser Permanente is “absolutely” sticking with the marketplaces, CEO Bernard Tyson told Modern Healthcare. Some peers that are fleeing exchanges, he said, priced low to gain market share and lost money when Congress underfunded the ACA's risk-adjustment program.
American Hospital Association Chairman Jim Skogsbergh says new CEO Rick Pollack has undertaken a tough leadership transition without being distracted from representing members on the policy front.